LTR Pharma Limited (AU:LTP) has released an update.
LTR Pharma Ltd has announced a fast-acting nasal spray for treating erectile dysfunction, aiming to provide investors with an overview of the company’s latest development. However, they caution that the presentation should not be seen as complete information for making investment decisions and contains forward-looking statements that are subject to various risks. The company disclaims any responsibility for the accuracy or completeness of the information provided.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.
